Jiangxi Kvvit Pharmaceutical Co.,Ltd.
As of 18 November 2026, for the company name Jiangxi Kvvit Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 18 active records with this name as holder; 37 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
97 acceptance records as first applicant, grouped into 58 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
KR25102片 · No verified English name 2 records · Latest accepted 2026/11/13
New drug · 2
KR23248胶囊 · No verified English name 4 records · Latest accepted 2026/11/05
New drug · 3Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601375 | New drug | 2026/11/05 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2601374 | New drug | 2026/11/05 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2600370 | Supplement | 2026/09/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2600180 | New drug | 2026/02/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Doxycycline Hyclate Tablets 1 records · Latest accepted 2026/11/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2602003 | Supplement | 2026/11/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
KR23343片 · No verified English name 6 records · Latest accepted 2026/09/29
New drug · 4Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601213 | New drug | 2026/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2601212 | New drug | 2026/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2600098 | Supplement | 2026/04/10 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2600097 | Supplement | 2026/04/10 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2501054 | New drug | 2025/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2501053 | New drug | 2025/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
玛舒拉沙韦片 · No verified English name 3 records · Latest accepted 2026/08/18
New drug · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600119 | New drug | 2026/08/18 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2600891 | Supplement | 2026/05/12 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2400256 | Supplement | 2024/11/27 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Brivaracetam Oral Solution 3 records · Latest accepted 2026/08/04
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601496 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2500486 | Generic | 2025/01/25 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHL2500019 | Generic | 2025/01/18 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Brivaracetam Tablets 6 records · Latest accepted 2026/08/04
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601498 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2601497 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2500188 | Supplement | 2025/01/23 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2500187 | Supplement | 2025/01/23 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2401106 | Supplement | 2024/07/25 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2401105 | Supplement | 2024/07/25 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
西诺氨酯片 · No verified English name 2 records · Latest accepted 2026/07/17
Generic · 2
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2026/06/25
Supplement · 2
玛舒拉沙韦干混悬剂 · No verified English name 2 records · Latest accepted 2026/05/28
New drug · 2
Enzalutamide Soft Capsules 2 records · Latest accepted 2026/05/14
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600927 | Supplement | 2026/05/14 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Ren Fu Pu Ke Pharma (Wuhan) Co., Ltd. romanized | CDE ↗ |
| CYHB2501795 | Supplement | 2025/09/09 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Ren Fu Pu Ke Pharma (Wuhan) Co., Ltd. romanized | CDE ↗ |
唑尼沙胺片 · No verified English name 1 records · Latest accepted 2026/04/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600853 | Supplement | 2026/04/30 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
注射用KR25102 · No verified English name 1 records · Latest accepted 2026/04/11
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600430 | New drug | 2026/04/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Lacosamide Tablets 4 records · Latest accepted 2026/04/09
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600717 | Supplement | 2026/04/09 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2600716 | Supplement | 2026/04/09 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2502210 | Supplement | 2025/10/28 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2502209 | Supplement | 2025/10/28 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
注射用DN022150 · No verified English name 5 records · Latest accepted 2026/03/17
New drug · 3Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600331 | New drug | 2026/03/17 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2600175 | New drug | 2026/02/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2500254 | Supplement | 2025/09/16 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHB2400172 | Supplement | 2024/08/06 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2400461 | New drug | 2024/05/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Finerenone Tablets 1 records · Latest accepted 2025/11/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503911 | Generic | 2025/11/08 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2025/10/31
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502250 | Supplement | 2025/10/31 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Eribulin Mesilate Injection 1 records · Latest accepted 2025/10/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502005 | Supplement | 2025/10/14 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jian Jin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Acetylcysteine Injection 1 records · Latest accepted 2025/06/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502048 | Generic | 2025/06/10 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
葡萄糖酸依诺沙星注射液 · No verified English name 2 records · Latest accepted 2025/06/04
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501124 | Supplement | 2025/06/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2501123 | Supplement | 2025/06/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
利多布比卡因注射液 · No verified English name 1 records · Latest accepted 2025/05/31
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501117 | Supplement | 2025/05/31 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Argatroban Injection 1 records · Latest accepted 2025/05/31
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501118 | Supplement | 2025/05/31 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Linaclotide Capsules 1 records · Latest accepted 2025/02/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500805 | Generic | 2025/02/20 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Apalutamide Tablets 1 records · Latest accepted 2025/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500463 | Generic | 2025/01/24 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Brivaracetam Solution for Injection 1 records · Latest accepted 2025/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500242 | Generic | 2025/01/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
阿贝西利片 · No verified English name 3 records · Latest accepted 2025/01/08
Generic · 3
KR230109乳膏 · No verified English name 2 records · Latest accepted 2025/01/03
New drug · 2
Methocarbamol Injection 1 records · Latest accepted 2024/12/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402175 | Supplement | 2024/12/20 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Lasmiditan Tablets 2 records · Latest accepted 2024/09/28
Generic · 2
依伏卡塞片 · No verified English name 2 records · Latest accepted 2024/09/10
Generic · 2
泊沙康唑注射液 · No verified English name 2 records · Latest accepted 2024/08/17
Supplement · 2
Ursodeoxycholic acid oral suspension 1 records · Latest accepted 2024/07/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402395 | Generic | 2024/07/30 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Mecobalamin Tablets 1 records · Latest accepted 2024/06/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400928 | Supplement | 2024/06/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Ruxolitinib Phosphate Tablets 1 records · Latest accepted 2024/06/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401878 | Generic | 2024/06/25 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Trazodone Hydrochloride Tablets 1 records · Latest accepted 2024/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400983 | Generic | 2024/04/01 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Regorafenib Tablets 1 records · Latest accepted 2024/02/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400234 | Supplement | 2024/02/07 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Perampanel Tablets 2 records · Latest accepted 2024/02/05
Supplement · 2
Dronedarone Hydrochloride Tablets 1 records · Latest accepted 2024/02/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400430 | Generic | 2024/02/01 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Acetylcysteine Effervescent Tablets 1 records · Latest accepted 2024/01/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400026 | Supplement | 2024/01/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Beraprost Sodium Tablets 1 records · Latest accepted 2023/12/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303507 | Generic | 2023/12/19 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Crisaborole Ointment 1 records · Latest accepted 2023/12/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303492 | Generic | 2023/12/16 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Perampanel oral suspension 1 records · Latest accepted 2023/11/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303309 | Generic | 2023/11/30 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Ibrutinib Capsules 1 records · Latest accepted 2023/10/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302871 | Generic | 2023/10/24 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Tedizolid Phosphate Tablets 1 records · Latest accepted 2023/10/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302330 | Supplement | 2023/10/20 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Atomoxetine Hydrochloride Oral Solution 1 records · Latest accepted 2023/09/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302040 | Supplement | 2023/09/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2023/09/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302428 | Generic | 2023/09/09 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Rasagiline Mesylate Tablets 1 records · Latest accepted 2023/08/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301777 | Supplement | 2023/08/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Flumazenil Injection 2 records · Latest accepted 2023/08/02
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301767 | Supplement | 2023/08/02 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2301766 | Supplement | 2023/08/02 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Urapidil Hydrochloride Injection 1 records · Latest accepted 2023/07/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301650 | Supplement | 2023/07/21 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Pregabalin Oral Solution 1 records · Latest accepted 2023/06/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301297 | Supplement | 2023/06/08 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Vancomycin Hydrochloride For Oral Solution 2 records · Latest accepted 2023/06/08
Supplement · 2
Tedizolid Phosphate For Injection 1 records · Latest accepted 2023/04/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300927 | Supplement | 2023/04/28 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
Lacosamide Oral Solution 1 records · Latest accepted 2022/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201789 | Supplement | 2022/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
肌苷口服溶液 · No verified English name 1 records · Latest accepted 2022/09/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201682 | Supplement | 2022/09/17 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
恩替卡韦分散片 · No verified English name 1 records · Latest accepted 2022/09/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201671 | Supplement | 2022/09/15 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
恩替卡韦胶囊 · No verified English name 1 records · Latest accepted 2022/09/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201675 | Supplement | 2022/09/15 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Lacosamide Injection 1 records · Latest accepted 2022/09/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201674 | Supplement | 2022/09/15 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Apixaban Tablets 1 records · Latest accepted 2022/09/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201672 | Supplement | 2022/09/15 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Changes in the last 90 days
9 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 7 applicationsNo longer listed under review: 2 applications
- 2026/11/17No longer listed under review
Vonoprazan Fumarate Tablets
CYHB2601185
Fact date: 2026/11/17 · Date added to this site: 2026/11/17
Accepted: 2026/06/25
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/17No longer listed under review
Vonoprazan Fumarate Tablets
CYHB2601184
Fact date: 2026/11/17 · Date added to this site: 2026/11/17
Accepted: 2026/06/25
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/13Accepted
KR25102片 · No verified English name
CXHL2601428
Fact date: 2026/11/13 · Date added to this site: 2026/11/14
View source ↗ - 2026/11/05Accepted
KR23248胶囊 · No verified English name
CXHL2601375
Fact date: 2026/11/05 · Date added to this site: 2026/11/06
View source ↗ - 2026/11/05Accepted
KR23248胶囊 · No verified English name
CXHL2601374
Fact date: 2026/11/05 · Date added to this site: 2026/11/06
View source ↗ - 2026/11/04Accepted
Doxycycline Hyclate Tablets
CYHB2602003
Fact date: 2026/11/04 · Date added to this site: 2026/11/05
View source ↗ - 2026/09/29Accepted
KR23343片 · No verified English name
CXHL2601213
Fact date: 2026/09/29 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/29Accepted
KR23343片 · No verified English name
CXHL2601212
Fact date: 2026/09/29 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/11Accepted
KR23248胶囊 · No verified English name
CXHB2600370
Fact date: 2026/09/11 · Date added to this site: 2026/10/22
View source ↗
Under review
18 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| KR25102片 · No verified English name | CXHL2601428 | New drug | 2026/11/13 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| KR23248胶囊 · No verified English name | CXHL2601375 | New drug | 2026/11/05 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| KR23248胶囊 · No verified English name | CXHL2601374 | New drug | 2026/11/05 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Doxycycline Hyclate Tablets | CYHB2602003 | Supplement | 2026/11/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
| KR23343片 · No verified English name | CXHL2601213 | New drug | 2026/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| KR23343片 · No verified English name | CXHL2601212 | New drug | 2026/09/29 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| KR23248胶囊 · No verified English name | CXHB2600370 | Supplement | 2026/09/11 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 玛舒拉沙韦片 · No verified English name | CXHS2600119 | New drug | 2026/08/18 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Brivaracetam Tablets | CYHB2601498 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Brivaracetam Tablets | CYHB2601497 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Brivaracetam Oral Solution | CYHB2601496 | Supplement | 2026/08/04 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2601713 | Generic | 2026/07/17 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2601712 | Generic | 2026/07/17 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 玛舒拉沙韦干混悬剂 · No verified English name | CXHS2600077 | New drug | 2026/05/28 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 玛舒拉沙韦片 · No verified English name | CYHB2600891 | Supplement | 2026/05/12 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 玛舒拉沙韦干混悬剂 · No verified English name | CXHS2500136 | New drug | 2025/11/14 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Finerenone Tablets | CYHS2503911 | Generic | 2025/11/08 | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2502048 | Generic | 2025/06/10 | Jiangxi Kvvit Pharmaceutical Co.,Ltd.; Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | CDE ↗ |
Catalogue holder records
18 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Linaclotide Capsules | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20266125 | 2026/09/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apalutamide Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20264465 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿贝西利片 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20264199 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brivaracetam Solution for Injection | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Qingfeng Pharmaceutical Co.,Ltd. | 国药准字H20264163 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿贝西利片 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20264200 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿贝西利片 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20264201 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ruxolitinib Phosphate Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20256441 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依伏卡塞片 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20256452 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依伏卡塞片 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20256453 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20254738 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dronedarone Hydrochloride Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20253890 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方匹可硫酸钠颗粒 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20253774 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Beraprost Sodium Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20253082 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ibrutinib Capsules | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20253113 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20247284 | 2024/11/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Regorafenib Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20244729 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Effervescent Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20243405 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | 国药准字H20243012 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
37 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 呋喹替尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000712 | I | 2026/08/12 | CDE ↗ |
| 甲苯磺酸尼拉帕利 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000577 | I | 2026/07/06 | CDE ↗ |
| 唑尼沙胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000398 | I | 2026/05/12 | CDE ↗ |
| 富马酸依美斯汀 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000177 | I | 2026/04/20 | CDE ↗ |
| 西诺氨酯 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000247 | I | 2026/03/30 | CDE ↗ |
| 贝前列素钠 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20260000011 | I | 2026/01/14 | CDE ↗ |
| 瑞卢戈利 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20250001150 | I | 2025/10/30 | CDE ↗ |
| 非奈利酮 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20250000942 | I | 2025/09/08 | CDE ↗ |
| 拉考沙胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20250000859 | A | 2026/11/13 | CDE ↗ |
| 阿贝西利 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20240001099 | A | 2026/04/21 | CDE ↗ |
| 米库氯铵 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20240000836 | A | 2026/08/08 | CDE ↗ |
| 依伏卡塞 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20240000703 | A | 2026/04/03 | CDE ↗ |
| 磷酸芦可替尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20240000491 | A | 2025/12/30 | CDE ↗ |
| 阿帕他胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20230001081 | A | 2026/06/27 | CDE ↗ |
| 玛舒拉沙韦 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20230000981 | A | 2026/10/11 | CDE ↗ |
| 伊布替尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20230000444 | A | 2025/04/26 | CDE ↗ |
| 克立硼罗 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20230000260 | A | 2025/08/01 | CDE ↗ |
| 布立西坦 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20220001288 | A | 2024/12/27 | CDE ↗ |
| 瑞戈非尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20220001135 | A | 2025/08/14 | CDE ↗ |
| 奥拉帕利 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20220001150 | A | 2025/12/31 | CDE ↗ |
| 匹可硫酸钠 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20220000894 | A | 2025/04/23 | CDE ↗ |
| 米拉贝隆 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000290 | A | 2024/12/27 | CDE ↗ |
| 吡仑帕奈 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210001085 | A | 2026/09/25 | CDE ↗ |
| 甲磺酸雷沙吉兰 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000995 | A | 2025/07/05 | CDE ↗ |
| 恩扎卢胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000970 | A | 2024/12/27 | CDE ↗ |
| 罗沙司他 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000730 | A | 2026/04/03 | CDE ↗ |
| 阿普米司特 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000755 | A | 2026/01/10 | CDE ↗ |
| 磷酸特地唑胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20210000660 | A | 2026/05/06 | CDE ↗ |
| 哌柏西利 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20200001440 | A | 2025/08/14 | CDE ↗ |
| 泊沙康唑 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20200001224 | A | 2024/12/27 | CDE ↗ |
| 甲磺酸仑伐替尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20200001168 | A | 2025/05/21 | CDE ↗ |
| 甲钴胺 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20190005609 | A | 2024/12/27 | CDE ↗ |
| 马来酸阿法替尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20190000816 | A | 2026/08/13 | CDE ↗ |
| 枸橼酸托法替布 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20190000372 | A | 2026/02/26 | CDE ↗ |
| 富马酸丙酚替诺福韦 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20180001316 | A | 2025/09/17 | CDE ↗ |
| 甲苯磺酸索拉非尼 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20180001005 | A | 2025/07/28 | CDE ↗ |
| 恩替卡韦 · No verified English name | Jiangxi Kvvit Pharmaceutical Co.,Ltd. | Y20170002183 | A | 2024/12/27 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Vonoprazan Fumarate Tablets | CYHS2502455 | Generic | 2025/07/09 | Jiangxi Shan Xiang Pharma Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2502454 | Generic | 2025/07/09 | Jiangxi Shan Xiang Pharma Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Sevelamer Carbonate Powder for oral suspension | CYHS2502009 | Generic | 2025/06/06 | Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Mivacurium Chloride Injection | CYHS2403580 | Generic | 2024/10/23 | Chengdu Nuo He Cheng Hong Biopharmaceutical Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Mivacurium Chloride Injection | CYHS2403579 | Generic | 2024/10/23 | Chengdu Nuo He Cheng Hong Biopharmaceutical Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| GP681片 · No verified English name | CXHS2300106 | New drug | 2023/11/25 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 阿普米司特片 · No verified English name | CYHB2302118 | Supplement | 2023/09/16 | Jiangxi Xin Zheng Pharma Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 阿普米司特片 · No verified English name | CYHB2302117 | Supplement | 2023/09/16 | Jiangxi Xin Zheng Pharma Co., Ltd. romanized; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Vancomycin Hydrochloride For Oral Solution | CYHS2300506 | Generic | 2023/02/14 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Vancomycin Hydrochloride For Oral Solution | CYHS2300505 | Generic | 2023/02/14 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Acetylcysteine Effervescent Tablets | CYHS2300427 | Generic | 2023/02/09 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Regorafenib Tablets | CYHS2300191 | Generic | 2023/01/19 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Tedizolid Phosphate Tablets | CYHS2200954 | Generic | 2022/06/28 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Rasagiline Mesylate Tablets | CYHS2200015 | Generic | 2022/01/06 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | CYHS2101990 | Generic | 2021/11/09 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 阿普米司特片 · No verified English name | CYHS2101972 | Generic | 2021/11/05 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| 阿普米司特片 · No verified English name | CYHS2101971 | Generic | 2021/11/05 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
| Atomoxetine Hydrochloride Oral Solution | CYHS2100121 | Generic | 2021/01/28 | Jiangxi Qingfeng Pharmaceutical Co.,Ltd.; Jiangxi Kvvit Pharmaceutical Co.,Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.